Hepatic iron accumulation is an independent risk factor for the development of hepatocellular carcinoma after interferon therapy in patients with chronic hepatitis C

Namiki Izumi(Musashino Red Cross Hospital), Takahiro Sakai(Japanese Red Cross Society, Japan), Yasuhiro Asahina(Tokyo Medical and Dental University), Osamu Noguchi, Nobuhiko Kanazawa(Musashino Red Cross Hospital), Masakatsu Uchihara(Musashino Red Cross Hospital), Shozo Miyake(Musashino Red Cross Hospital), Jun Itakura(Musashino Red Cross Hospital)
Gastroenterology
April 1, 2001
10.1016/s0016-5085(08)80381-2
Cited by 1

Related Papers

Randomised, multicentre prospective trial of transarterial chemoembolisation (TACE) plus sorafenib as compared with TACE alone in patients with hepatocellular carcinoma: TACTICS trial
|Gut|2019|732
Clinical practice guidelines for hepatocellular carcinoma: The Japan Society of Hepatology 2017 (4th JSH‐HCC guidelines) 2019 update
|Hepatology Research|2019|539
Aryne-based strategy in the total synthesis of naturally occurring polycyclic compounds
|Chemical Society Reviews|2018|293
Some Properties of the Products of Reaction of Tadpole Collagenase with Collagen<sup>*</sup>
|Biochemistry|1967|246
Orantinib versus placebo combined with transcatheter arterial chemoembolisation in patients with unresectable hepatocellular carcinoma (ORIENTAL): a randomised, double-blind, placebo-controlled, multicentre, phase 3 study
|˜The œLancet. Gastroenterology & hepatology|2017|200